AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2015
Jun 26, 2015
32870_dirs_2015-06-26_0d3811ce-ce13-4049-85a2-f5770de8b7b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-06-24
Reporting Person: Havey Adam (EVP, Biodefense Divison)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-24 | Common Stock | M | 10238 | $18.9 | Acquired | 41076 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-24 | Stock Option | $18.90 | M | 10238 | Acquired | 2016-03-09 | Common Stock (10238) | Direct |
Footnotes
F1: Consists of an option granted under the company's stock incentive plan on March 10, 2009.
F2: The option vested in three equal installments in March 2010, 2011 and 2012
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3